Trial
NCT06400589
A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease
Phase IIISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
HanAll BioPharma Co., Ltd.
Collaborators
—
Condition
Dry Eye
Intervention
tanfanercept
Why stopped
Logistical issue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-31